Adam S. Grossman, President and CEO at ADMA BIOLOGICS, INC. (ADMA), sold 27,000 shares at $18.92 ($511K) on 2025-03-19, disclosed to the SEC on 2025-03-21.
Scheduled sale ($511k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.92 | 6,000 | $114K | 22.2% |
| 2 | $18.92 | 6,000 | $114K | 22.2% |
| 3 | $18.92 | 15,000 | $284K | 55.6% |
| Total | $18.92 avg | 27,000 | $511K | 100% |
| Filing → |
| ADMA | SELL | 2025-12-16 | $416K | — | Filing → |
| ADMA | SELL | 2025-11-21 | $336K | — | Filing → |
| ADMA | SELL | 2025-10-24 | $336K | — | Filing → |